Purchase Short-Term Access

Review: Anticoagulation with INRs < 2 or between 3 and 5 increases risk for thromboembolic or hemorrhagic events

Anne Holbrook, MD, PharmD

Annals of Internal Medicine 2008;149:JC5-5. doi:10.7326/0003-4819-149-10-200811180-02005

Purchase Online access to this article for 24 hours

Annals of Internal Medicine

Forgot Your Password?

to gain full access to the content and tools.

Learn more about subscription options

Forgot your password?

Enter your username and email address. We'll send you a reminder to the email address on record.

Username* (Required)

Email Address* (Required)